Glipizide
- Product NDC
- 51655-106
- 11-digit product format
- 516550106
- Labeler code
- 51655
- Product ID
- 51655-106_48c31243-aa64-8632-e063-6294a90a138c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2014-12-30
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 51655-106-25 | 2023-12-18 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-26 | 2023-12-18 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-52 | 2023-12-18 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-25 | 2023-01-30 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-26 | 2023-01-30 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-52 | 2023-01-30 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-25 | 2021-01-04 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-26 | 2021-01-04 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-52 | 2021-01-04 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-25 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-26 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
| 51655-106-52 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f07a-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 10 mg Rx Only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-106-25 | Glipizide | 60 in 1 BOTTLE, DISPENSING | TABLET | 60 | | 6 |
| 51655-106-26 | Glipizide | 90 in 1 BOTTLE, DISPENSING | TABLET | 90 | | 6 |
| 51655-106-52 | Glipizide | 30 in 1 BOTTLE, DISPENSING | TABLET | 30 | | 6 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-106 | GLIPIZIDE TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20231219_0ed5ed22-dd53-495d-bc10-0bede4d87926.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-106-25 | 51655010625 | 60 TABLET in 1 BOTTLE, DISPENSING (51655-106-25) | 60 tablet | 2014-12-30 | 0000-00-00 | No | No | Current |
| 51655-106-26 | 51655010626 | 90 TABLET in 1 BOTTLE, DISPENSING (51655-106-26) | 90 tablet | 2014-12-30 | 0000-00-00 | No | No | Current |
| 51655-106-52 | 51655010652 | 30 TABLET in 1 BOTTLE, DISPENSING (51655-106-52) | 30 tablet | 2014-12-30 | 0000-00-00 | No | No | Current |